Pharmaceuticals

Nutraceutical Excipients Market Expansion to $1.4 Billion by 2029: Key Drivers and Trends

December 3, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the nutraceutical excipients market from 2025–2034 with trusted insights from The Business Research Company

What Is The Base Market Size For The Nutraceutical Excipients Market Today And What Will It Reach By 2029?

The phosphoramidite market size has demonstrated robust growth in recent years. This market is set to expand from $1.01 billion in 2024 to $1.07 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.1%. The historical growth trajectory can be attributed to factors such as the increasing demand for DNA and RNA synthesis, the rising adoption of mRNA-based therapeutics, the growing prevalence of genetic disorders, the expanding demand for synthetic biology, and enhanced investments in genomic research.

The phosphoramidite market is poised for significant expansion in the coming years. Projections indicate it will reach $1.4 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 7.0%. This anticipated growth during the forecast period is primarily driven by the increasing application of phosphoramidites, a surge in demand for tailored DNA and RNA synthesis, the escalating requirement for high-purity phosphoramidites, an intensified emphasis on personalized medicine, and the proliferation of biopharmaceutical firms. Key trends shaping the forecast period encompass the expansion of synthetic biology, the creation of innovative phosphoramidite chemistries, progress in genomic technologies, ongoing development efforts within biotechnology, and the evolution of personalized medicine.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22096&type=smp

What Factors Are Boosting The Nutraceutical Excipients Market?

The growth of the phosphoramidite market is expected to be propelled by the expanding biopharmaceutical sector going forward. This sector encompasses the industry involved in the research, development, production, and commercialization of medical products derived from biological sources, such as vaccines, gene therapies, monoclonal antibodies, and recombinant proteins. The expansion of the biopharmaceutical sector is attributed to advancements in biotechnology, the increasing prevalence of chronic diseases, and rising investments in research and development. Innovations in biotechnology, including gene editing and monoclonal antibody therapies, have led to more effective and targeted treatments. The burgeoning biopharmaceutical sector will boost phosphoramidite demand, as these compounds play a crucial role in synthesizing DNA and RNA for gene therapies, mRNA vaccines, and oligonucleotide-based drugs. As these treatments gain wider adoption, the requirement for phosphoramidites to produce synthetic nucleic acids will increase, thereby enhancing their use in biopharmaceutical research and production. For example, according to the UK government, the core biopharmaceutical sector generated £46.7 ($58.4 billion) billion in revenue during 2022, accounting for 43% of the life sciences industry’s total turnover. Additionally, this sector supports over 126,000 jobs and has shown substantial growth in research and development investments. Consequently, the expansion of the biopharmaceutical sector is a key driver for the growth of the phosphoramidite market.

How Is The Nutraceutical Excipients Market Categorized By Application, Type, And Region?

The phosphoramidite market covered in this report is segmented –

1) By Type: Deoxyribonucleic Acid (DNA) Phosphoramidites, Ribonucleic Acid (RNA) Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites, Other Types

2) By Synthesis Method: H-Phosphonate Method, Phosphoramidite Method, Trivalent Phosphorus Compounds Method

3) By Application: Gene Synthesis, Deoxyribonucleic Acid (DNA) Sequencing, Deoxyribonucleic Acid (DNA) Amplification

4) By End-User: Academic Research, Pharmaceutical Industry, Biotechnology Industry

Subsegments:

1) By Deoxyribonucleic Acid (DNA) Phosphoramidites: Standard DNA Phosphoramidites, Degenerate DNA Phosphoramidites, Methylated DNA Phosphoramidites, Backbone-Modified DNA Phosphoramidites

2) By Ribonucleic Acid (RNA) Phosphoramidites: Standard RNA Phosphoramidites, 2′-O-Methyl RNA Phosphoramidites, 2′-Fluoro RNA Phosphoramidites, 2′-O-TBDMS Protected RNA Phosphoramidites

3) By Labeled Phosphoramidites: Fluorescent-Labeled Phosphoramidites, Biotin-Labeled Phosphoramidites, Digoxigenin-Labeled Phosphoramidites, Radioisotope-Labeled Phosphoramidites

4) By Modifier Phosphoramidites: Amine-Modified Phosphoramidites, Thiol-Modified Phosphoramidites, Spacer Phosphoramidites, Azide-Modified Phosphoramidites

5) By Other Types: Chimeric Phosphoramidites, Phosphorothioate Phosphoramidites, PEGylated Phosphoramidites, Photo-Cleavable Phosphoramidites

How Are Technological Trends Affecting The Nutraceutical Excipients Market Growth?

Major companies operating in the phosphoramidite market are concentrating on developing advanced DNA synthesis services aimed at boosting accuracy, speed, and sustainability while reducing hazardous waste in DNA manufacturing. DNA synthesis represents a method for creating DNA sequences utilizing enzymes instead of chemical reagents, thus providing greater accuracy, speed, and sustainability. For instance, in April 2022, Ansa Biotechnologies Inc., a US-based biotechnology company, announced the completion of an oversubscribed $68 million Series A financing round. This funding initiative was led by Northpond Ventures and saw participation from various new and existing investors. The capital secured is intended to accelerate the advancement of Ansa’s next-generation enzymatic DNA synthesis technology, also known as phosphoramidite synthesis, to expand its R&D and manufacturing facilities, and to launch a customizable DNA synthesis service. The company, which spun out from the University of California, Berkeley, employs a patented technique that enables the rapid and precise synthesis of long DNA sequences, thereby addressing existing industry bottlenecks.

Who Are The Global Leaders Steering The Nutraceutical Excipients Market Forward?

Major companies operating in the phosphoramidite market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Aragen Life Sciences, Twist Bioscience, Innovassynth Technologies (I) Ltd., Tokyo Chemical Industry Co. Ltd. (TCI), Aurigene Services, Eurofins Genomics, LGC Biosearch Technologies, Link Technologies Ltd., Creative Biolabs, Biosynth Carbosynth, TriLink BioTechnologies, ChemGenes Corporation, Berry & Associates Inc., Lumiprobe Corporation, Hongene Biotech Corporation, Carbolink India Pvt. Ltd., PolyOrg Inc., Glen Research, Gene Link Inc., emp BIOTECH GmbH

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/phosphoramidite-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Nutraceutical Excipients Market?

North America was the largest region in the phosphoramidite market in 2024. Europe is expected to be the fastest-growing region during the forecast period. The regions covered in the phosphoramidite market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=22096&type=smp

Browse Through More Reports Similar to the Global Nutraceutical Excipients Market 2025, By The Business Research Company

Viral Vectors And Plasmid Dna Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report

Dna Based Skin Care Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dna-based-skin-care-products-global-market-report

Dna And Gene Chip Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795